Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B Warren

Showing results (151-160 of 909) with videos related to

Pageof 91
Sort By:
The American Sociologist|July 1, 1990
Permissions and the social contextCarol A B Warren, Tracy X Karner
Cutis|January 20, 2021
High-grade ovarian serous carcinoma presenting as androgenetic alopeciaAnna Eversman, Elisabeth Tracey, Christine B Warren
British Journal of Clinical Pharmacology|March 13, 2012
Symmetrical analysis of risk-benefitJohn B Warren, Simon Day, Peter Feldschreiber
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
The future of biological therapiesRichard B Warren, Christopher E M Griffiths
Physical Review Letters|April 20, 2004
Enhancement of the stability of genetic switches by overlapping upstream regulatory domainsPatrick B Warren, Pieter Rein ten Wolde
The Journal of Physical Chemistry. B|July 21, 2006
Chemical models of genetic toggle switchesPatrick B Warren, Pieter Rein ten Wolde
The British Journal of Dermatology|October 18, 2005
The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasisR B Warren, C E M Griffiths
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2020
Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis - time for a paradigm changeM Nogueira, R B Warren, T Torres
Expert Review of Clinical Immunology|December 31, 2013
Treating moderate to severe psoriasis - best use of biologicsMaeve Lynch, Brian Kirby, Richard B Warren
American Journal of Clinical Dermatology|March 1, 2016
Novel Oral Therapies for Psoriasis and Psoriatic ArthritisZenas Z N Yiu, Richard B Warren
Pageof 91

Showing results (151-160 of 909) with videos related to

Sort By:
Pageof 91
The American Sociologist|July 1, 1990
Permissions and the social contextCarol A B Warren, Tracy X Karner
Cutis|January 20, 2021
High-grade ovarian serous carcinoma presenting as androgenetic alopeciaAnna Eversman, Elisabeth Tracey, Christine B Warren
British Journal of Clinical Pharmacology|March 13, 2012
Symmetrical analysis of risk-benefitJohn B Warren, Simon Day, Peter Feldschreiber
Seminars in Cutaneous Medicine and Surgery|May 1, 2010
The future of biological therapiesRichard B Warren, Christopher E M Griffiths
Physical Review Letters|April 20, 2004
Enhancement of the stability of genetic switches by overlapping upstream regulatory domainsPatrick B Warren, Pieter Rein ten Wolde
The Journal of Physical Chemistry. B|July 21, 2006
Chemical models of genetic toggle switchesPatrick B Warren, Pieter Rein ten Wolde
The British Journal of Dermatology|October 18, 2005
The potential of pharmacogenetics in optimizing the use of methotrexate for psoriasisR B Warren, C E M Griffiths
Journal of the European Academy of Dermatology and Venereology : JEADV|August 14, 2020
Risk of tuberculosis reactivation with interleukin (IL)-17 and IL-23 inhibitors in psoriasis - time for a paradigm changeM Nogueira, R B Warren, T Torres
Expert Review of Clinical Immunology|December 31, 2013
Treating moderate to severe psoriasis - best use of biologicsMaeve Lynch, Brian Kirby, Richard B Warren
American Journal of Clinical Dermatology|March 1, 2016
Novel Oral Therapies for Psoriasis and Psoriatic ArthritisZenas Z N Yiu, Richard B Warren
Pageof 91